It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study examines if overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms, and if these variables could be modified after 1 year of a multimodal intervention (diet, physical activity, psychosocial support). 342 adults (55–75 years) with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus Cognition study were randomized to the intervention or to the control group (lifestyle recommendations). Cognitive and psychopathological assessments were performed at baseline and after 1-year follow-up. At baseline, higher impulsivity was linked to higher food addiction and depressive symptoms, but not to body mass index (BMI). Food addiction not only predicted higher BMI and depressive symptoms, but also achieved a mediational role between impulsivity and BMI/depressive symptoms. After 1 year, patients in both groups reported significant decreases in BMI, food addiction and impulsivity. BMI reduction and impulsivity improvements were higher in the intervention group. Higher BMI decrease was achieved in individuals with lower impulsivity. Higher scores in food addiction were also related to greater post-treatment impulsivity. To conclude, overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms in mid/old age individuals with MetS. Our results also highlight the modifiable nature of the studied variables and the interest of promoting multimodal interventions within this population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Addictive Behaviours Unit, Department of Psychiatry, Barcelona, Spain (GRID:grid.413396.a) (ISNI:0000 0004 1768 8905); University Hospital of Bellvitge-IDIBELL, Department of Psychiatry, Barcelona, Spain (GRID:grid.411129.e) (ISNI:0000 0000 8836 0780); Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
2 University Hospital of Bellvitge-IDIBELL, Department of Psychiatry, Barcelona, Spain (GRID:grid.411129.e) (ISNI:0000 0000 8836 0780); Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
3 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Integrative Pharmacology and Neurosciences Systems, Barcelona, Spain (GRID:grid.20522.37) (ISNI:0000 0004 1767 9005)
4 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, Reus, Spain (GRID:grid.410367.7) (ISNI:0000 0001 2284 9230); Institut d’Investigació Sanitària Pere Virgili (IISPV), Reus, Spain (GRID:grid.420268.a) (ISNI:0000 0004 4904 3503); Universitat Rovira i Virgili (URV), Serra Hunter Fellow, Reus, Spain (GRID:grid.410367.7) (ISNI:0000 0001 2284 9230)
5 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University Hospital of Bellvitge, Lipids and Vascular Risk Unit, Internal Medicine, Hospitalet de Llobregat, Barcelona, Spain (GRID:grid.411129.e) (ISNI:0000 0000 8836 0780)
6 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University of Valencia, Department of Preventive Medicine, Valencia, Spain (GRID:grid.5338.d) (ISNI:0000 0001 2173 938X)
7 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Departament de Psicobiologia i Metodologia, Cerdanyola del Vallès, Barcelona, Spain (GRID:grid.7080.f)
8 University Hospital of Bellvitge-IDIBELL, Department of Psychiatry, Barcelona, Spain (GRID:grid.411129.e) (ISNI:0000 0000 8836 0780); Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University of Barcelona, Department of Clinical Sciences, School of Medicine and Health Sciences, Hospitalet de Llobregat, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
9 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, Reus, Spain (GRID:grid.410367.7) (ISNI:0000 0001 2284 9230); Institut d’Investigació Sanitària Pere Virgili (IISPV), Reus, Spain (GRID:grid.420268.a) (ISNI:0000 0004 4904 3503)
10 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, Reus, Spain (GRID:grid.410367.7) (ISNI:0000 0001 2284 9230); Institut d’Investigació Sanitària Pere Virgili (IISPV), Reus, Spain (GRID:grid.420268.a) (ISNI:0000 0004 4904 3503); University Hospital of Sant Joan de Reus, Nutrition Unit, Reus, Spain (GRID:grid.411136.0) (ISNI:0000 0004 1765 529X)
11 Instituto de Salud Carlos III (ISCIII), Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Integrative Pharmacology and Neurosciences Systems, Barcelona, Spain (GRID:grid.20522.37) (ISNI:0000 0004 1767 9005); Experimentals i de la Salut Universitat Pompeu Fabra (CEXS-UPF), Departament de Ciències, Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676)